SCHEMBL5022876

SCHEMBL5022876

Cc1cc(CC(C)C)c(C)cc1CN

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
CYP1A2 P05177 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP7 P55210 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5015066 0.86 ALDH1A1 (0.34) ALDH1A1GABRA1GABRB2NOS3NOS1
SCHEMBL3669420 0.83 ALDH1A1 (0.48) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL6572888 0.80 ALDH1A1 (0.61) ALDH1A1GABRA1GABRB2NOS3NOS1
Hydrochloric Acid SCHEMBL4115150 0.80 ALDH1A1 (0.46) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL14957365 0.78 ALDH1A1 (0.44) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL11851884 0.77 ALDH1A1 (0.46) ALDH1A1GABRA1GABRB2NOS3NOS1
SCHEMBL23387413 0.76 GABRA1 (0.52) ALDH1A1GABRA1GABRB2ALOX15CASP7
SCHEMBL22863402 0.76 GABRA1 (0.34) ALDH1A1GABRA1GABRB2
SCHEMBL2683313 0.76 CYP1A2 (0.37) ALDH1A1GABRA1GABRB2CYP1A2
SCHEMBL10019203 0.76 LMNA (0.39) ALDH1A1GABRA1GABRB2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed